Alcon AG (ALC.SW) stock: key figures, P/E, revenue and dividend

Health Care · Switzerland · ISIN CH0432492467

Price
64.57 CHF
Market cap
32.04 bn CHF
P/E (2025)
31.79
P/S (2025)
3.02
Dividend yield
0.52 %
Net margin
9.42 %
Return on equity (ROE)
4.54 %
Return on assets (ROA)
3.17 %

Alcon AG financials

Fiscal year20242025
Revenue9.91 bn USD10.61 bn USD
Gross profit5.51 bn USD5.86 bn USD
Operating income1.37 bn USD1.27 bn USD
EBIT1.41 bn USD1.39 bn USD
Net income1.02 bn USD999.69 m USD
Diluted EPS – continuing operations2.04 USD2.03 USD

Full history since 2015, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Alcon AG

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 14.10.2026. Details in the risk notice.

Alcon AG stock (ALC.SW): P/E, revenue, dividend | finmetric